Sep 17, 2020

Drug-Coated Balloon For Peripheral Artery Disease

Information about the minimally invasive procedure to treat peripheral artery disease (PAD) using IN.PACT Admiral drug-coated balloon.

The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.

Dec 21, 2014
Results of IN.PACT SFA Trial Published in Circulation

MINNEAPOLIS -- Dec. 22, 2014 -- The results of a landmark study published this month in Circulation, the world's leading cardiovascular journal, indicate that a novel medical device from...

Feb 19, 2015
CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Standard of Care for Peripheral Arterial Disease in Upper Leg

DUBLIN - Feb. 19, 2015 - Medtronic plc (NYSE: MDT) announced today that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company's...

Jan 5, 2015
Pivotal Study Shows New Medical Device Provides Exceptional Clinical Outcomes and Reduces Need for Costly Repeat Procedures

MINNEAPOLIS -- Jan. 5, 2015 -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's IN.PACT Admiral drug-coated balloon (DCB) for...

Feb 4, 2015
First Uses of New Medical Device Following FDA Approval Take Place at Hospitals Nationwide

DUBLIN – Feb. 4, 2015 – U.S. hospitals this week began using a new medical device from Medtronic plc (NYSE: MDT) called the IN.PACT Admiral drug-coated balloon (DCB) to treat patients with...